• Bobcat339: TET Inhibition to Decipher Epigenetic Regulation

  2026-05-03

  This thought-leadership article explores the mechanistic and translational potential of Bobcat339, a cytosine structure-based TET enzyme inhibitor, within the context of DNA methylation, super-enhancer dynamics, and osteogenic differentiation. Drawing from recent multi-omics studies in senile osteoporosis, it provides actionable guidance for researchers navigating epigenetic targets in bone biology, highlighting Bobcat339's role in advancing the study of gene transcription modulation and DNA methylation regulation. The article bridges foundational epigenetics with emerging therapeutic strategies, offering protocol insights, workflow maturity, and a forward-looking perspective.

• Moxifloxacin Workflows: Applied Use-Cases and Troubleshootin

  2026-05-02

  Moxifloxacin stands out as a fluoroquinolone antibiotic uniquely suited for probing antibiotic toxicity, cellular proliferation, and metabolic responses in both in vitro and in vivo research. This guide delivers actionable protocols, optimization strategies, and evidence-backed troubleshooting tips, leveraging APExBIO’s reliable supply of Moxifloxacin to ensure reproducible results.

• NEIL1 Regulates COL17A1 to Promote Colorectal Cancer Initiat

  2026-05-02

  This study uncovers a mechanistic link between oxidative DNA repair and colorectal cancer (CRC) initiation by demonstrating that NEIL1 upregulation enhances tumorigenesis via transcriptional activation of COL17A1. The findings highlight NEIL1 as a potential therapeutic target, especially in combination with NF-κB inhibition, for modulating the immunosuppressive microenvironment in CRC.

• Modified Ethanol Injection Enables Efficient mRNA Lipoplex D

  2026-05-01

  Tang et al. demonstrate that the modified ethanol injection (MEI) method produces mRNA lipoplexes with high protein expression efficiency both in vitro and in vivo. This approach offers a simplified, equipment-light alternative for mRNA delivery, with potential implications for vaccine and gene therapy development.

• Spermine Tetrahydrochloride: Mechanistic Insights Into Membr

  2026-04-30

  Discover the unique mechanistic role of Spermine tetrahydrochloride in membrane stabilization and neurobiological assays. This article offers a rigorous, evidence-based analysis grounded in primary research and experimental protocols.

• Annexin V-APC/7-AAD Apoptosis Kit: Precision Apoptosis Detec

  2026-04-30

  The Annexin V-APC/7-AAD Apoptosis Kit delivers rapid, dual-color discrimination of apoptosis and necrosis, empowering high-resolution cell fate analysis in cancer and immunology research. Its one-step protocol streamlines workflows and is validated against the latest immune evasion findings, setting a new benchmark for apoptosis detection kits.

• Taltirelin Suppresses Acute and Chronic Itch in Murine Model

  2026-04-29

  This study provides the first systematic evidence that Taltirelin, a thyrotropin-releasing hormone analog, robustly inhibits both acute and chronic itch in mice. The findings extend Taltirelin's known neuropharmacological actions and highlight its translational value for preclinical antipruritic research.

• TSPAN18 Drives STIM1 Stability and Bone Metastasis in Prosta

  2026-04-29

  Zhou et al. (2023) uncover how TSPAN18 stabilizes STIM1 by blocking TRIM32-mediated ubiquitination, thereby promoting bone metastasis in prostate cancer. This mechanistic insight into the STIM1-Ca2+ axis presents TSPAN18 as a promising target in hormone-responsive cancer research.

• AG-120 (Ivosidenib): Applied Workflows for Mutant IDH1 Inhib

  2026-04-28

  Harness AG-120 (Ivosidenib) for precise inhibition of mutant IDH1 and robust 2-hydroxyglutarate reduction in AML research. This guide details experimental optimizations, troubleshooting, and translational insights for improved, reproducible differentiation assays.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Protocol Evidence &

  2026-04-28

  The HRP Rabbit Anti-Goat IgG (H+L) Antibody is a horseradish peroxidase conjugated secondary antibody designed for precise immunodetection of goat primary antibodies. Its affinity-purified format ensures minimal background and high specificity across ELISA, western blot, and immunohistochemistry assays. This article delivers protocol guidance, verifiable performance data, and boundaries for its optimal research application.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Use Guide

  2026-04-27

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific detection of goat IgG in fluorescence-based assays where signal amplification and low background are critical. It is not suited for primary antibodies from species other than goat or non-immunodetection workflows. Proper handling and protocol adherence are essential for robust, reproducible results.

• Mechanistic Insights into Gepotidacin and DNA Gyrase Inhibit

  2026-04-27

  The referenced study provides a detailed mechanistic and structural analysis of the novel antibacterial gepotidacin, revealing its unique interaction with Staphylococcus aureus DNA gyrase. These findings inform antibiotic mechanism-of-action research, especially in the context of fluoroquinolone resistance and the development of next-generation gyrase inhibitors.

• Dabigatran in Thromboembolic Disorders: Mechanistic and Tran

  2026-04-26

  This article reviews the pivotal study on dabigatran's role as a direct thrombin inhibitor for thromboembolic disease prevention and treatment. The findings illustrate its clinical advantages over traditional vitamin K antagonists, emphasizing improved safety, simplified dosing, and the impact on future anticoagulant research.

• Lyso-Tracker Red: Quantitative Insights Into Lysosome Dynami

  2026-04-25

  Explore how Lyso-Tracker Red enables precise, quantitative analysis of lysosomal distribution and function in live cells. This in-depth article reveals new assay strategies and protocol optimizations for high-resolution lysosome tracking, building on recent breakthroughs in cancer research.

• Z-VEID-FMK: Caspase-6 Inhibitor Workflows for Advanced Apopt

  2026-04-24

  Z-VEID-FMK’s specificity and irreversible inhibition make it a gold-standard tool for dissecting caspase-6-dependent cell death in neuronal, immune, and cancer models. This guide delivers actionable workflows, protocol optimizations, and troubleshooting strategies to maximize reproducibility and insight, anchored by cutting-edge research and the reliability of APExBIO quality.

16084 records 1/1073 page Next 12345 下5页 Last page